These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9929677)

  • 1. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction.
    Bacon AW; Bondi MW; Salmon DP; Murphy C
    Ann N Y Acad Sci; 1998 Nov; 855():723-31. PubMed ID: 9929677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons.
    Murphy C; Bacon AW; Bondi MW; Salmon DP
    Ann N Y Acad Sci; 1998 Nov; 855():744-50. PubMed ID: 9929680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory Dysfunction in ApoE ɛ4/4 Homozygotes with Alzheimer's Disease.
    Oleson S; Murphy C
    J Alzheimers Dis; 2015; 46(3):791-803. PubMed ID: 25869786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory identification and apolipoprotein E epsilon 4 allele in mild cognitive impairment.
    Wang QS; Tian L; Huang YL; Qin S; He LQ; Zhou JN
    Brain Res; 2002 Sep; 951(1):77-81. PubMed ID: 12231459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals.
    Rebeck GW; Perls TT; West HL; Sodhi P; Lipsitz LA; Hyman BT
    Neurology; 1994 Aug; 44(8):1513-6. PubMed ID: 8058160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease].
    Korovaĭtseva GI; Shcherbatykh TV; Selezneva NV; Gavrilova SI; Golimbet VE; Voskresenskaia NI; Rogaev EI
    Genetika; 2001 Apr; 37(4):529-35. PubMed ID: 11421127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the ApoE epsilon4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer's disease, probable Alzheimer's disease, and healthy elderly controls.
    Gilbert PE; Murphy C
    J Clin Exp Neuropsychol; 2004 Sep; 26(6):779-94. PubMed ID: 15370375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E, memory and Alzheimer's disease.
    Soininen HS; Riekkinen PJ
    Trends Neurosci; 1996 Jun; 19(6):224-8. PubMed ID: 8761956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
    Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
    JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoE epsilon 4 allelic association with Alzheimer's disease: independent confirmation using denaturing gradient gel electrophoresis.
    Peacock ML; Fink JK
    Neurology; 1994 Feb; 44(2):339-41. PubMed ID: 8309587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
    Aerssens J; Raeymaekers P; Lilienfeld S; Geerts H; Konings F; Parys W
    Dement Geriatr Cogn Disord; 2001; 12(2):69-77. PubMed ID: 11173877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.
    Saunders AM; Strittmatter WJ; Schmechel D; George-Hyslop PH; Pericak-Vance MA; Joo SH; Rosi BL; Gusella JF; Crapper-MacLachlan DR; Alberts MJ
    Neurology; 1993 Aug; 43(8):1467-72. PubMed ID: 8350998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E polymorphism and Alzheimer's disease.
    Poirier J; Davignon J; Bouthillier D; Kogan S; Bertrand P; Gauthier S
    Lancet; 1993 Sep; 342(8873):697-9. PubMed ID: 8103819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease.
    Galasko D; Saitoh T; Xia Y; Thal LJ; Katzman R; Hill LR; Hansen L
    Neurology; 1994 Oct; 44(10):1950-1. PubMed ID: 7936253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E polymorphism and Alzheimer's disease.
    Yen YC; Liu CK; Lung FW; Chong MY
    Kaohsiung J Med Sci; 2001 Apr; 17(4):190-7. PubMed ID: 11482130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfaction in aging and Alzheimer's disease: event-related potentials to a cross-modal odor-recognition memory task discriminate ApoE epsilon4+ and ApoE epsilon 4- individuals.
    Murphy C; Solomon ES; Haase L; Wang M; Morgan CD
    Ann N Y Acad Sci; 2009 Jul; 1170():647-57. PubMed ID: 19686207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.
    Hashimoto M; Yasuda M; Tanimukai S; Matsui M; Hirono N; Kazui H; Mori E
    Neurology; 2001 Oct; 57(8):1461-6. PubMed ID: 11673590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions.
    Egensperger R; Bancher C; Kösel S; Jellinger K; Mehraein P; Graeber MB
    Biochem Biophys Res Commun; 1996 Jul; 224(2):484-6. PubMed ID: 8702415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease.
    Growdon JH; Locascio JJ; Corkin S; Gomez-Isla T; Hyman BT
    Neurology; 1996 Aug; 47(2):444-8. PubMed ID: 8757018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.